Home › Amarantus Requests Rare Pediatric Disease Designation From FDA
 

Keywords :   


Amarantus Requests Rare Pediatric Disease Designation From FDA

2016-02-09 01:17:54| drugdiscoveryonline News Articles

Amarantus BioScience Holdings, Inc.(OTCQB: AMBS),a biotechnology company focused on developing products for Regenerative Medicine, Neurology and Orphan Diseases, announced that it has requested Rare Pediatric Disease Designation (RPDD) from the US Food and Drug Administration (FDA) for treating retinitis pigmentosa (RP) with MANF.

Tags: disease requests rare designation

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.115 2 PG
24.11215103TW 17svtw
24.11 Switch light
24.11Dr.SLUMP 19
24.11layover LP
24.11PING i230 6W 5
24.11BTS CD
24.11HG 56
More »